{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:37:17Z","timestamp":1777495037960,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jpedsurg.2021.02.039","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T02:21:58Z","timestamp":1614133318000},"page":"1157-1164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["PIM447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastoma"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-5921","authenticated-orcid":false,"given":"Nikita","family":"Wadhwani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-5614","authenticated-orcid":false,"given":"Hooper R.","family":"Markert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2848-3927","authenticated-orcid":false,"given":"Raoud","family":"Marayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3833-0657","authenticated-orcid":false,"given":"Laura V","family":"Bownes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-3948","authenticated-orcid":false,"given":"Colin H.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-1263","authenticated-orcid":false,"given":"Jamie M.","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry E.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0830-571X","authenticated-orcid":false,"given":"Karina J.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Beierle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpedsurg.2021.02.039_bib0001","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40880-019-0411-7","article-title":"Incidence trends and survival prediction of hepatoblastoma in children: a population-based study","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun"},{"issue":"3","key":"10.1016\/j.jpedsurg.2021.02.039_bib0002","doi-asserted-by":"crossref","DOI":"10.1097\/MOP.0000000000000081","article-title":"Management of hepatoblastoma: an update","volume":"26","author":"Kremer","year":"2014","journal-title":"Curr Opin Pediatr"},{"issue":"10","key":"10.1016\/j.jpedsurg.2021.02.039_bib0003","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/hpb.12112","article-title":"Predictors of survival and incidence of hepatoblastoma in the paediatric population","volume":"15","author":"Allan","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"3","key":"10.1016\/j.jpedsurg.2021.02.039_bib0004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15430\/JCP.2018.23.3.109","article-title":"PIM kinase as an executional target in cancer","volume":"23","author":"Zhang","year":"2018","journal-title":"J Cancer Prev"},{"issue":"32","key":"10.1016\/j.jpedsurg.2021.02.039_bib0005","doi-asserted-by":"crossref","first-page":"22665","DOI":"10.18632\/oncotarget.25205","article-title":"Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma","volume":"9","author":"Stafman","year":"2018","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.jpedsurg.2021.02.039_bib0006","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jpedsurg.2019.02.029","article-title":"The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival","volume":"54","author":"Stafman","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"2","key":"10.1016\/j.jpedsurg.2021.02.039_bib0007","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tranon.2018.10.008","article-title":"Targeting PIM kinases affects maintenance of CD133 tumor cell population in hepatoblastoma","volume":"12","author":"Stafman","year":"2019","journal-title":"Transl Oncol"},{"issue":"39","key":"10.1016\/j.jpedsurg.2021.02.039_bib0008","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11457","article-title":"Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447","volume":"7","author":"Peters","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.jpedsurg.2021.02.039_bib0009","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1038\/s41375-019-0482-0","article-title":"The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and\/or refractory multiple myeloma","volume":"33","author":"Raab","year":"2019","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.jpedsurg.2021.02.039_bib0010","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou\u2013Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jpedsurg.2021.02.039_bib0011","first-page":"70","article-title":"ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays","volume":"347","author":"Hu","year":"2009","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/j.jpedsurg.2021.02.039_bib0012","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1\u20133","key":"10.1016\/j.jpedsurg.2021.02.039_bib0013","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.febslet.2004.06.050","article-title":"Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site","volume":"571","author":"Aho","year":"2004","journal-title":"FEBS Lett."},{"issue":"4\u20135","key":"10.1016\/j.jpedsurg.2021.02.039_bib0014","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.drup.2011.04.002","article-title":"The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms","volume":"14","author":"Isaac","year":"2011","journal-title":"Drug Resist Updat"},{"issue":"13","key":"10.1016\/j.jpedsurg.2021.02.039_bib0015","doi-asserted-by":"crossref","first-page":"10880","DOI":"10.18632\/oncotarget.3534","article-title":"PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma","volume":"6","author":"CO-n","year":"2015","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.jpedsurg.2021.02.039_bib0016","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/onc.2009.504","article-title":"Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver","volume":"29","author":"Wu","year":"2010","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.jpedsurg.2021.02.039_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215410","article-title":"Insights into the interaction mechanisms of the proviral integration site of Moloney Murine Leukemia Virus (Pim) Kinases with Pan-Pim Inhibitors PIM447 and AZD1208: a molecular dynamics simulation and MM\/GBSA calculation study","volume":"20","author":"Chen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpedsurg.2021.02.039_bib0018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fped.2016.00022","article-title":"A need for cell lines and tissue banks to develop targeted drug therapies","volume":"4","author":"Rikhi","year":"2016","journal-title":"Front Pediatr"},{"issue":"9","key":"10.1016\/j.jpedsurg.2021.02.039_bib0019","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.jpedsurg.2021.02.039_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jss.2008.03.033","article-title":"Serine\/Threonine Kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell","volume":"153","author":"Gong","year":"2009","journal-title":"J Surg Res"},{"issue":"1","key":"10.1016\/j.jpedsurg.2021.02.039_bib0021","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1158\/1078-0432.CCR-16-0230","article-title":"The novel Pan-PIM Kinase Inhibitor, PIM447, displays dual antimyeloma and bone-protective effects, and potently synergizes with current standards of care","volume":"23","author":"Pa\u00edno","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.jpedsurg.2021.02.039_bib0022","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ijc.20719","article-title":"Aberrant expression of serine\/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines","volume":"114","author":"Fujii","year":"2005","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.jpedsurg.2021.02.039_bib0023","doi-asserted-by":"crossref","first-page":"24706","DOI":"10.3390\/ijms141224706","article-title":"Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma","volume":"14","author":"Alisi","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jpedsurg.2021.02.039_bib0024","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v8i6.2163","article-title":"Novel therapeutics in hepatoblastoma","volume":"8","author":"Wadhwani","year":"2020","journal-title":"Med Res Arch"},{"issue":"4","key":"10.1016\/j.jpedsurg.2021.02.039_bib0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/0971-9261.142001","article-title":"The treatment of hepatoblastoma: its evolution and the current status as per the SIOPEL trials","volume":"19","author":"Aronson","year":"2014","journal-title":"J Indian Assoc Pediatr Surg"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346821001731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346821001731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:39:30Z","timestamp":1758357570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346821001731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0022346821001731"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2021.02.039","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PIM447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2021.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}